The University of North Carolina at Chapel Hill, a leading global public research university with significant expertise in HIV basic and clinical research, and GSK, a global, research-based pharmaceutical and healthcare company with a legacy of success in developing treatments for HIV, today announced the creation of the dedicated HIV Cure center and a jointly owned new company that will focus on discovering a cure for HIV/AIDS. This unique public-private partnership will redefine the traditional way of conducting research and create a new model to seek the breakthroughs needed to tackle an extraordinarily challenging global health issue.
![](https://secure.gravatar.com/avatar/021380cc8d4a8224d9652a471c5dce88?s=80&d=https%3A%2F%2Fbigbendcares.org%2Fwp-content%2Fthemes%2Fdt-the7%2Fimages%2Fmask.png&r=g)